RoActemra, also known as tocilizumab, is a medication approved by the Food and Drug Administration (FDA) in the USA. It is used to treat severe COVID-19, as well as conditions like rheumatoid arthritis, systemic juvenile idiopathic arthritis, and juvenile idiopathic polyarthritis under the brand name Actemra.